(Hedgeweek) Activist hedge fund firm Starboard Value has built a $1bn position in Pfizer and is planning to push for strategic changes at the pharmaceutical giant as the company grapples with declining post-pandemic revenues, according to a report by the Wall Street Journal.
Activist Starboard acquires $1bn Pfizer stake
This entry was posted in Syndicated. Bookmark the permalink.
